Clinical Remission in Severe Asthma: How to Move From Theory to Practice

Andrew Menzies-Gow; David Price

doi:10.1016/j.chest.2023.03.001

Clinical Remission in Severe Asthma: How to Move From Theory to Practice

Andrew Menzies-Gow^* (Corresponding Author), David Price

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Pages (from-to)	296-298
Number of pages	3
Journal	Chest
Volume	164
Issue number	2
Early online date	7 Aug 2023
DOIs	https://doi.org/10.1016/j.chest.2023.03.001
Publication status	Published - 7 Aug 2023

Bibliographical note

ACKNOWLEDGMENTS
Medical writing support was provided by Dan Jackson, PhD, CMPP, of CiTRUS Health Group, which was in accordance with Good Publication Practice (GPP4) guidelines. AstraZeneca (Cambridge, UK) funded this support. AMG and DBP both conceived and refined the topic for this manuscript. Both authors contributed to the
discussion and revision of the content and approved the final version.

Keywords

biologics
remission
severe asthma

Access to Document

10.1016/j.chest.2023.03.001Licence: Unspecified

Menzies_etal_CJ_Clinical_Remission_In_AAM
©2023. This manuscript version is made available under the CC-BY https://creativecommons.org/licenses/by/4.0/
Accepted author manuscript, 171 KBLicence: CC BY

Cite this

@article{8a41358137e241ea8dd6e824b9eb36d5,

title = "Clinical Remission in Severe Asthma: How to Move From Theory to Practice",

keywords = "biologics, remission, severe asthma",

author = "Andrew Menzies-Gow and David Price",

note = "ACKNOWLEDGMENTS Medical writing support was provided by Dan Jackson, PhD, CMPP, of CiTRUS Health Group, which was in accordance with Good Publication Practice (GPP4) guidelines. AstraZeneca (Cambridge, UK) funded this support. AMG and DBP both conceived and refined the topic for this manuscript. Both authors contributed to the discussion and revision of the content and approved the final version. ",

year = "2023",

month = aug,

day = "7",

doi = "10.1016/j.chest.2023.03.001",

language = "English",

volume = "164",

pages = "296--298",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "2",

}

TY - JOUR

T1 - Clinical Remission in Severe Asthma

T2 - How to Move From Theory to Practice

AU - Menzies-Gow, Andrew

AU - Price, David

N1 - ACKNOWLEDGMENTS Medical writing support was provided by Dan Jackson, PhD, CMPP, of CiTRUS Health Group, which was in accordance with Good Publication Practice (GPP4) guidelines. AstraZeneca (Cambridge, UK) funded this support. AMG and DBP both conceived and refined the topic for this manuscript. Both authors contributed to the discussion and revision of the content and approved the final version.

PY - 2023/8/7

Y1 - 2023/8/7

KW - biologics

KW - remission

KW - severe asthma

UR - http://www.scopus.com/inward/record.url?scp=85166916135&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2023.03.001

DO - 10.1016/j.chest.2023.03.001

M3 - Article

C2 - 37558327

SN - 0012-3692

VL - 164

SP - 296

EP - 298

JO - Chest

JF - Chest

IS - 2

ER -

Clinical Remission in Severe Asthma: How to Move From Theory to Practice

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this